Compare III & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | III | SENS |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | 1500 | N/A |
| Industry | Professional Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.1M | 496.0M |
| IPO Year | 2006 | 2014 |
| Metric | III | SENS |
|---|---|---|
| Price | $5.20 | $8.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.50 | ★ $18.38 |
| AVG Volume (30 Days) | 175.4K | ★ 664.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ 216.67 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $192,745,000.00 | $16,389,000.00 |
| Revenue This Year | $3.85 | $74.15 |
| Revenue Next Year | $4.34 | $58.60 |
| P/E Ratio | $42.17 | ★ N/A |
| Revenue Growth | 4.51 | ★ 19.85 |
| 52 Week Low | $3.74 | $0.41 |
| 52 Week High | $6.45 | $10.15 |
| Indicator | III | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 55.02 |
| Support Level | $3.86 | $5.13 |
| Resistance Level | $5.36 | $10.07 |
| Average True Range (ATR) | 0.15 | 0.55 |
| MACD | -0.03 | -0.18 |
| Stochastic Oscillator | 46.97 | 20.01 |
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.